• Mutation; HGNC; 11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
  

PubMed=22358567; DOI=10.1007/BF00146816
Hosoi S., Mioh H., Anzai C., Sato S., Fujiyoshi N.
Establishment of Namalva cell lines which grow continuously in glutamine-free medium.
Cytotechnology 1:151-158(1988)

PubMed=1366592; DOI=10.1007/BF00143675
Miyaji H., Mizukami T., Hosoi S., Sato S., Fujiyoshi N., Itoh S.
Expression of human beta-interferon in Namalwa KJM-1 which was adapted to serum-free medium.
Cytotechnology 3:133-140(1990)

PubMed=1369278; DOI=10.1007/BF00148809
Miyaji H., Harada N., Mizukami T., Sato S., Fujiyoshi N., Itoh S.
Expression of human lymphotoxin in Namalwa KJM-1 cells adapted to serum-free medium.
Cytotechnology 4:39-43(1990)

DOI=10.1007/978-94-011-2044-9_9
Hosoi S., Satoh M., Miyaji H., Nishi T., Mizukami T., Hasegawa M., Itoh S., Tamaoki T.
Stable production of pro-urokinase and its derivative by Namalwa KJM-1 cells adapted to a serum-free medium.
(In book chapter) Animal cell technology. Basic and applied aspects, Vol. 5; Kaminogawa S., Ametani A., Hachimura S. (eds.); pp.63-70; Springer; Dordrecht; Netherlands (1993)